The BCCH BioBank supports a number of research projects on campus at BC Children’s Hospital and BC Women’s Hospital + Health Centre, as well as off campus and with industry partners. Below are some current research projects we are involved with.

General Biobank

General Biobank applications: Sample requests received between 2024-2025

  • Dr. David Harriman (UBC); Examining Urinary Microbiome Changes in Pediatric Renal Transplant Recipients. 
  • Dr. Crystal Karakochuk; Examining the Association Between Maternal and Infant Iron Status from a Cohort of Births in Vancouver, BC. 
  • Drs. Anastasia Drobysheva and Dave Grynspan (UBC, UBCO); A Feasibility Study: Placental Research Collaboration between BC Women’s Hospital Pathology Department, UBC Okanogan Department of Chemistry, and BC Children’s Hospital BioBank. 
  • Dr. Robbie Majzner (Harvard); Immunotherapy for Pediatric Sarcomas.
  • Amgen; Development of a human multi-cellular engineered living culture system. 
  • BRAvE; Personalize Molecular Characterization. 
  • Dr. Tom Blydt-Hansen; Enhanced immune monitoring in pediatric kidney transplant recipients (EnMo I). 
  • Dr. Gregor Reid; Overcoming the barriers to successful immune therapy for acute leukemia.

Investigator-driven research: Studies started between 2024-2025

  • Dr. Wendy Robinson; The contribution of genetic variation in the placenta to congenital heart defects (EPIC-HEART)
  • Dr. Jay Kizhakkedathu (UBC); Blood antigen regeneration kinetics after enzymatic cleavage: kidney vascular system in-vitro model (IVARM)
  • Dr. Kirk Schultz; A randomized, double-blind, multicenter, Phase 3 study to evaluate efficacy and safety of belumosudil in combination with corticosteroids versus placebo in combination with corticosteroids in participants at least 12 years of age with newly diagnosed chronic graft versus host disease (cGVHD) (RocknRol)
  • Dr. Audi Setiadi, Evaluation of Automated Plasma Cytokine Analysis for Cytokine Release Syndrome (CRS)
  • Dr. David Dix; A Phase 1/2 Trial of Selinexor (KPT-330) and Radiation Therapy in Newly-Diagnosed Pediatric Diffuse Intrinsic Pontine Glioma (DIPG) and High-Grade Glioma (HGG) (ACNS1821)
  • Dr. Mary Connolly; A Phase 3b/4, Interventional, Multicenter, Open-Label, Single-Arm Study to Assess Behavioral and Other Co-occurring Outcomes Following Treatment With EPID(I/Y)OLEX (EpiCom)
  • Dr. Ted Steiner; A study to measure food sensitivities in children and adolescents with Eosinophilic Esophagitis (EoE) and Food Protein Induced Enterocolitis (FPIES)
  • Dr. Dina Panagiotopoulos, Precision Diabetes Study (PDS)
  • Dr. William Honer (UBC), Honer Lab Anti-synaptic Antibodies (WGH Cell Lines)
  • Dr. Rod Rassekh; A Randomized, Double-Blind Tolerability Trial of Cannabinoids for Symptom Management in Children with Cancer (CAN-PONC)
  • Dr. Edmond Chan; A phase I/II trial in 3 parts assessing the safety, tolerability, and efficacy of a once-daily peanut sublingual immunotherapy (SLIT) tablet in adults, adolescents, and children with peanut allergy (ALK)